Biovail Corporation is an international, fully integrated pharmaceutical company with special capabilities in the development, manufacture, sale and marketing of branded pharmaceutical products.
Eugene Melnyk has been Chairman since March 1994, and assumed the role of Chief Executive Officer in December 2001. Prior to joining Biovail Mr. Melnyk was President and CEO of a company he founded, Trimel Corp. – a publisher of medical journals and one of Canada’s leading trade publishers.
In his discussion Mr. Melnyk will reflect on the challenges of growing a North American pharmaceutical business from Canada competing with the giant global multinational companies with market caps in excess of $100 billion, annual revenue in excess of $20 billion and that spend upwards of half a billion dollars developing and launching a product. Biovail has grown from a $100 million company in 1998 and company expectations are $1 billion next year.
Please note special pricing: $40 Members, $45 Non-members, $425 Tables of ten.
